Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
Address:
9 Jeffrey orchard
NW1 North Joshuaville (United Kingdom)
ID: 8029-862360-6 (ECI)
Report
Date: 09-JAN-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 09-JAN-2023

Chemistry

Test 09-JAN-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 156.8 H 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.7 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.8 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 139.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.8 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.2 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.8 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 250.3 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 366.6 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 146.0 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.9 L 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 2.4 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated fasting glucose, total cholesterol, LDL cholesterol, and triglycerides, with low HDL cholesterol, indicating poorly controlled dyslipidemia and impaired glucose metabolism, increasing cardiovascular risk. Renal function and microalbumin/creatinine ratio are within normal limits. Recommend clinical follow-up for metabolic syndrome and cardiovascular risk management.